Protocol No.: D763QC00001

Title
A Phase III, Randomised, Open-Label, Multicentre Study of Datopotamab Deruxtecan or Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung17)
Principal Investigator
Bhasin, Pooja Gogia
Phase
III (Cancer Control)
Age Group
Adult
Applicable Disease Site
Lung Cancer
Participating Institutions
Mary Babb Randolph Cancer Center
West Virginia University
Contact
Rachel Harper
Clinical Research Specialist
Phone: +1 304-293-6066

View on ClinicalTrials.gov